IREN
IREN Limited
There isn't enough reported data to score IREN yet.
TCBX
Third Coast Bancshares, Inc.
TCBX's fundamentals are mixed: revenue grew 25%, but its operating margin fell 3 points to 37%. At 10x earnings, it's trading in line with its usual 11x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
TCBX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
TCBX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like TCBX.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
TCBX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.7x | $39.68 | — |
| Cheap | 9.9x | $38.58 | -2.8% |
| Current | 10x | $39.68 | — |
| Fair | 11x | $41.75 | +5.2% |
| Expensive | 12x | $47.55 | +20% |
Historical ranges are pointers, not guarantees.
TCBX's PE is in its cheap range at 10x. If earnings grow as analysts expect, today's price would be 9.7x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
TCBX Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TCBX, but weaker profitability.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
TCBX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | +4.6% |
| Q3 2026 | $3.91 | +9.5% |
| Q2 2026 | $4.01 | +22% |
| Q1 2026 | $3.89 | +32% |
| Q4 2025 | $3.79 | +36% |
| Q3 2025 | $3.57 | +39% |
| Q2 2025 | $3.28 | +53% |
| Q1 2025 | $2.95 | +45% |
| Q4 2024 | $2.78 | +40% |
TCBX has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
TCBX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65.9M | +21% |
| Q2 2026 | $68M | +31% |
| Q1 2026 | $57.7M | +26% |
| Q4 2025 | $56.5M | +22% |
| Q3 2025 | $54.5M | +27% |
| Q2 2025 | $52M | +25% |
| Q1 2025 | $45.9M | +14% |
| Q4 2024 | $46.3M | +17% |
TCBX's revenue has grown year over year every quarter since late 2022: $66M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -5.8 points |
| Q2 2026 | 40% | 0 points |
| Q1 2026 | 33% | -4.9 points |
| Q4 2025 | 38% | -0.6 points |
| Q3 2025 | 42% | +4 points |
| Q2 2025 | 40% | +6.4 points |
| Q1 2025 | 38% | +5.8 points |
| Q4 2024 | 39% | +8.4 points |
TCBX has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
TCBX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.9M | -57% |
| Q2 2026 | $45M | +224% |
| Q1 2026 | -$38.7M | -469% |
| Q3 2025 | $20.7M | -5.8% |
| Q2 2025 | $13.9M | +90% |
| Q1 2025 | $10.5M | +11% |
| Q3 2024 | $22M | +1077% |
| Q2 2024 | $7.3M | -22% |
TCBX has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over TCBX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
TCBX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +101K shares |
| 1 year | +18% | +3M shares |
| 3 years | +21% | +3.6M shares |
TCBX has 20M diluted shares, up 18% from a year ago.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
TCBX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -3.6x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -2.5x | Net Cash |
| Q4 2024 | -4.9x | Net Cash |
TCBX has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like TCBX.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
TCBX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.3 | Neutral |
| Stochastic | 7.5 | Oversold |
TCBX's weekly RSI is 43 (neutral) and its Stochastic is 8 (oversold).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
TCBX PE vs Financial Services Sector
| Metric | TCBX | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 22% below |
| PE % | 26 | 64 | 38 pts below |
TCBX is trading at 10x earnings, a 22% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
TCBX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.9 | 3.1% below |
| 20 week MA | $42.6 | 6.7% below |
| 50 week MA | $40.6 | 2.3% below |
| 100 week MA | $37.7 | 5.2% above |
| 200 week MA | $29.1 | 36% above |
TCBX has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
TCBX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.1 | $25.9 | +3.3% |
| 2022 | $25.9 | $18.5 | -28% |
| 2023 | $18.5 | $19.9 | +7.2% |
| 2024 | $19.9 | $34.1 | +72% |
| 2025 | $34.1 | $39.4 | +15% |
| 2026 YTD | $39.4 | $39.7 | +0.7% |
TCBX has the edge over IREN on returns for 2026, with the stronger performance.